Genetic and clinical contributions to cerebral palsy: A multi-variable analysis

Journal of Paediatrics and Child Health

Volumn 49, Issue 7, 2013, Pages 575-581

  O'Callaghan, Michael E ^a   Maclennan, Alastair H ^a   Gibson, Catherine S ^a   McMichael, Gai L ^a   Haan, Eric A ^a,b   Broadbent, Jessica L ^a   Baghurst, Peter A ^a,b   Goldwater, Paul N ^a,b   Dekker, Gustaaf A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

case control; cerebral palsy; infection; interaction; pregnancy; SNP

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GELATINASE A; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MANNOSE BINDING LECTIN; NEUROPEPTIDE Y; PLASMINOGEN ACTIVATOR INHIBITOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE CONTROL; CEREBRAL PALSY; INFECTION; INTERACTION; PREGNANCY; SNP;

CEREBRAL PALSY; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYTOKINES; FEMALE; GENOTYPING TECHNIQUES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MANNOSE-BINDING LECTIN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MOTHERS; MULTIVARIATE ANALYSIS; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOPHILIA;

EID: 84880201328     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12279     Document Type: Article

References (24)

1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev. Med. Child Neurol. Suppl. 2007; 109: 8-14.
2. Stanley F, Blair E, Alberman E,. Cerebral Palsies: Epidemiology and Causal Pathways. London: Mac Keith Press, 2000.
3. Andersen GL, Irgens LM, Haagaas I, Skranes JS, Meberg AE, Vik T,. Cerebral palsy in Norway: prevalence, subtypes and severity. Eur. J. Paediatr. Neurol. 2008; 12: 4-13.
4. Arneson CL, Durkin MS, Benedict RE, et al. Prevalence of cerebral palsy: autism and developmental disabilities monitoring network, three sites, United States, 2004. Disabil. Health J. 2009; 2: 45-48.
5. Paneth N, Hong T, Korzeniewski S,. The descriptive epidemiology of cerebral palsy. Clin. Perinatol. 2006; 33: 251-267.
6. Mayer PS, Wingate MB,. Obstetric factors in cerebral palsy. Obstet. Gynecol. 1978; 51: 399-406.
7. Jacobsson B, Ahlin K, Francis A, Hagberg G, Hagberg H, Gardosi J,. Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG 2008; 115: 1250-1255.
8. O'Shea TM, Klinepeter KL, Meis PJ, Dillard RG,. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants. Paediatr. Perinat. Epidemiol. 1998; 12: 72-83.
9. Tioseco JA, Aly H, Essers J, Patel K, El-Mohandes AA,. Male sex and intraventricular hemorrhage. Pediatr. Crit. Care Med. 2006; 7: 40-44.
10. Hemminki K, Li X, Sundquist K, Sundquist J,. High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr. Perinat. Epidemiol. 2007; 21: 235-241.
11. O'Callaghan ME, MacLennan AH, Haan EA, Dekker G,. The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum. Genet. 2009; 126: 149-172.
12. Wu D, Zou YF, Xu XY, et al. The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev. Med. Child Neurol. 2011; 53: 217-225.
13. O'Callaghan ME, MacLennan AH, Gibson CS, et al. The Australian cerebral palsy research study-protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. J. Paediatr. Child Health 2011; 47: 99-110.
14. O'Callaghan ME, Maclennan AH, Gibson CS, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics 2012; 129: e414-423.
15. O'Callaghan ME, MacLennan AH, Gibson CS, et al. Epidemiologic associations with cerebral palsy. Obstet. Gynecol. 2011; 118: 576-582.
16. McMichael GL, Gibson CS, O'Callaghan ME, et al. DNA from buccal swabs suitable for high-throughput SNP multiplex analysis. J. Biomol. Tech. 2009; 20: 232-235.
17. Hollegaard MV, Skogstrand K, Thorsen P, Norgaard-Pedersen B, Hougaard DM, Grove J,. Joint analysis of SNPs and proteins identifies regulatory IL18 gene variations decreasing the chance of spastic cerebral palsy. Hum. Mutat. 2012; 34: 143-148.
18. Costantine MM, Clark EA, Lai Y, et al. Association of polymorphisms in neuroprotection and oxidative stress genes and neurodevelopmental outcomes after preterm birth. Obstet. Gynecol. 2012; 120: 542-550.
19. Clark EA, Mele L, Wapner RJ, et al. Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Am. J. Obstet. Gynecol. 2010; 203: 83 e1-e10.
20. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B Methodological. 1995; 57: 289-300.
21. Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122: 1079-1085.
22. Wu YW, Croen LA, Vanderwerf A, Gelfand AA, Torres AR,. Candidate genes and risk for CP: a population-based study. Pediatr. Res. 2011; 70: 642-646.
23. Martin MC, Martinez A, Mendoza JL, et al. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics 2007; 59: 833-837.
24. Barcellos LF, Begovich AB, Reynolds RL, et al. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann. Neurol. 2004; 55: 793-800.